Yan-yu Hou

Guangdong Provincial Key Laboratory For Diagnosis And Treatment Of Breast Cancer
Shantou, 515041, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Retraction notice to "Repurposed itraconazole for use in the treatment of malignancies as a promising therapeutic strategy" [Biomedicine & Pharmacotherapy 154 (2022) 113616].

Retraction notice to "Repurposed itraconazole for use in the treatment of malignancies as a promising therapeutic strategy" [Biomedicine & Pharmacotherapy 154 (2022) 113616].

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: May 01, 2026

Association between circadian rhythm-related behaviors and breast cancer: a bidirectional Mendelian randomization study.

Association between circadian rhythm-related behaviors and breast cancer: a bidirectional Mendelian randomization study.

Journal: Future science OA

Published: February 27, 2026

Causal relationship between subhealth status and pan-cancer risk: A Mendelian randomization study.

Causal relationship between subhealth status and pan-cancer risk: A Mendelian randomization study.

Journal: Medicine

Published: August 01, 2025

Bioinformatics-based multi-omics and machine learning analysis identifies stemness-associated molecular subtypes and a prognostic index in breast cancer.

Bioinformatics-based multi-omics and machine learning analysis identifies stemness-associated molecular subtypes and a prognostic index in breast cancer.

Journal: Translational cancer research

Published: April 21, 2025

Tumor Heterogeneity of STEAP4 in Malignant Progression of Oral Squamous Cell Carcinoma.

Tumor Heterogeneity of STEAP4 in Malignant Progression of Oral Squamous Cell Carcinoma.

Journal: Journal of Cancer

Published: July 26, 2024

SIX4, a potential therapeutic target for estrogen receptor-positive breast cancer patients, is associated with low promoter methylation level.

SIX4, a potential therapeutic target for estrogen receptor-positive breast cancer patients, is associated with low promoter methylation level.

Journal: Epigenomics

Published: October 31, 2023

Inflammatory response in gastrointestinal cancers: Overview of six transmembrane epithelial antigens of the prostate in pathophysiology and clinical implications.

Inflammatory response in gastrointestinal cancers: Overview of six transmembrane epithelial antigens of the prostate in pathophysiology and clinical implications.

Journal: World journal of clinical oncology

Published: October 27, 2023

Application of three-dimensional (3D) bioprinting in anti-cancer therapy.

Application of three-dimensional (3D) bioprinting in anti-cancer therapy.

Journal: Heliyon

Published: August 30, 2023

NOTCH3 inhibits transcription factor ZEB1 expression and metastasis of breast cancer cells via transcriptionally upregulating miR-223.

NOTCH3 inhibits transcription factor ZEB1 expression and metastasis of breast cancer cells via transcriptionally upregulating miR-223.

Journal: Journal of Cancer

Published: August 10, 2023

Lomitapide repurposing for treatment of malignancies: A promising direction.

Lomitapide repurposing for treatment of malignancies: A promising direction.

Journal: Heliyon

Published: August 04, 2023

Immune responses of six-transmembrane epithelial antigen of the prostate 4 functions as a novel biomarker in gastric cancer.

Immune responses of six-transmembrane epithelial antigen of the prostate 4 functions as a novel biomarker in gastric cancer.

Journal: World journal of clinical oncology

Published: May 10, 2023

Comprehensive analysis of cell-extracellular matrix protein Ras suppressor-1 in function and prognosis of gastrointestinal cancers.

Comprehensive analysis of cell-extracellular matrix protein Ras suppressor-1 in function and prognosis of gastrointestinal cancers.

Journal: World journal of methodology

Published: March 27, 2023

Showing 1-12 of 16

Last Updated: 09/26/2026